We believe in the educational merits of Free Open Access Medical education (FOAM), which includes p
In this podcast, we review Cerebral Vein Thrombosis (CVT) including clinical presentation, diagnosis
In this episode, we discuss ivermectin as a potential therapeutic for COVID-19 and review available
In this episode, we review new registry data from the ACIP meeting on pregnant people who received
In this episode, we review the FDA briefing document on the Janssen (Johnson & Johnson) viral vector
We have previously covered epistaxis on FOAMcast , including the use of tranexamic acid (TXA). Now,
There's been a lot of excitement over various drugs for COVID-19, including anti-inflammatory drugs.
Early studies of tocilizumab, a monoclonal antibody that binds interleukin-6 , were disappointing. H
As vaccinations role out, the news of SARS-CoV-2 variants with mutations to the spike protein have d
Prior randomized trials of convalescent plasma in COVID-19 have had disappointing results. However,
In this quick literature update we review the new recommendations from the CDC for the treatment of
For years studies have questioned whether pulse oximeters perform as well in non-White patients as i
Despite multiple Phase II/III vaccine trials of >30,000 participants, pregnant patients or those who
We interrupt our normal FOAMcast episodes to bring you updates from COVID-19. *Our understanding of
In this episode, we review cannabinoid hyperemesis syndrome and two recent randomized controlled tri
We spoonfeed you a new article on risk stratification of pulmonary embolism (with critical appraisal
